Algea Therapies introduces SHIELD Vertebral Compression Fracture System Algea Therapies.

The system includes the C3 Curved Osteotome, a steerable, unipedicular, curving cavity creator with an flexible blade. This instrument allows physicians to make a central cavity spanning the sagittal midline for balanced cement augmentation. The C3 Curved Osteotome has the ability to steer and navigate around damaged and tough anatomy, creating cavities to complement the anatomical requirements of each fracture.. Algea Therapies introduces SHIELD Vertebral Compression Fracture System Algea Therapies, a division of Globus Medical Inc. With this innovative platform technology, Algea is establishing a new regular for safer treatment of vertebral compression fractures, commented Sean Suh, Senior Group Supervisor of Algea Therapies.The CORE Stage II rules are advancing what sort of healthcare industry communicates, stated Ronald A. Williams, CEO of Aetna and CAQH plank chairman. We are investing in an infrastructure that’s improving connection and operability among healthcare providers and payers, while assisting to fulfill the priorities of the national health IT agenda. This ongoing advancement can increase effectiveness and quality through more timely access to key healthcare data. We encourage all industry stakeholders to be CORE-certified strongly. The CORE rules complement the national solutions outlined by the American Recovery and Reinvestment Act and its own Health IT for Economic and Clinical Health Action.